|
|
Sunita R. Patel, John H. Hartwig, Joseph E. Italiano
J Clin Invest. 2005;
115(12):3348
doi:10.1172/JCI26891
Abstract |
Full text
| PDF
P
latelets are formed and released into the bloodstream by precursor cells called megakaryocytes that reside within the bone marrow. The production of platelets by megakaryocytes requires an intricate series of remodeling events that result in the release of thousands of platelets from a single megakaryocyte. Abnormalities in this process can result in clinically significant disorders. Thrombocytopenia (platelet counts less than 150,000/μl) can lead to inadequate clot formation and increased risk of bleeding, while thrombocythemia (platelet counts greater than 600,000/μl) can heighten the risk for thrombotic events, including stroke, peripheral ischemia, and myocardial infarction. This Review will describe the process of platelet assembly in detail and discuss several disorders that affect platelet production.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(27)
| Title and authors |
Publication |
Year |
Fibronectin promotes proplatelet formation in the human megakaryocytic cell line UT-7/TPO
Tatsuya Kawaguchi, Ryo Hatano, Kyoji Yamaguchi, Katsuhiko Nawa, Ryuji Hashimoto, Hiroshi Yokota
|
Cell. Biol. Int.
|
2012 |
Blood platelet production and morphology
Alessandro Malara, Alessandra Balduini
|
Thrombosis Research
|
2012 |
Calcium- and integrin-binding protein 1 regulates megakaryocyte ploidy, adhesion, and migration
J. C. Kostyak, M. U. Naik, U. P. Naik
|
Blood
|
2012 |
Dasatinib enhances megakaryocyte differentiation but inhibits platelet formation.
Alexandra Mazharian, Cedric Ghevaert, Lin Zhang, Steffen Massberg, Steve P Watson
|
Blood
|
2011 |
Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets
E. C. Josefsson, C. James, K. J. Henley, M. A. Debrincat, K. L. Rogers, M. R. Dowling, M. J. White, E. A. Kruse, R. M. Lane, S. Ellis
|
Journal of Experimental Medicine
|
2011 |
Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum
Adriana Vieira-de-Abreu, Robert A. Campbell, Andrew S. Weyrich, Guy A. Zimmerman
|
Semin Immunopathol
|
2011 |
Three-Dimensional System for theIn VitroStudy of Megakaryocytes and Functional Platelet Production Using Silk-Based Vascular Tubes
Isabella Pallotta, Michael Lovett, David L. Kaplan, Alessandra Balduini
|
Tissue Engineering Part C: Methods
|
2011 |
Regulatory effects of TLR2 on megakaryocytic cell function
L. M. Beaulieu, E. Lin, K. M. Morin, K. Tanriverdi, J. E. Freedman
|
Blood
|
2011 |
Mutations responsible for MYH9-related thrombocytopenia impair SDF-1-driven migration of megakaryoblastic cells :
A. Pecci, V. Bozzi, E. Panza, S. Barozzi, C. Gruppi, M. Seri, C. L. Balduini
|
Thromb Haemost
|
2011 |
A copper–hydrogen peroxide redox system induces dityrosine cross-links and chemokine oligomerisation
Helen J. MacGregor, Yoji Kato, Lindsay J. Marshall, Thomas G. Nevell, Janis K. Shute
|
Cytokine
|
2011 |
|